Skip to main content

Table 2 Admission unit and underlying diseases of patient

From: A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital

Underlying diseases

Total, n = 38

ST group, n = 20

MT group, n = 18

Renal transplantation, [%. no.]

50.00 (19)

50.00(10)

50.00(9)

Haematological malignancies, [%. no.]

15.79(6)

20.00(4)

11.11(2)

Nephropathy, [%. no.]

7.89(3)

5.00(1)

11.11(2)

Vasculitis, [%. no.]

7.89(3)

5.00(1)

11.11(2)

Lupus erythematosus, [%. no.]

7.89(3)

10.00(2)

5.56(1)

Polymyositis, [%. no.]

5.26(2)

5.00(1)

5.56(1)

Mediastinal sacroma, [%. no.]

2.63(1)

0.00(0)

5.56(1)

Herpes zoster, [%. no.]

2.63(1)

5.00(1)

0.00(0)

  1. ST group, synergic therapy group; MT group, monotherapy group